New PET tracer aims to spot hidden cancer spread in the abdomen
NCT ID NCT07702292
First seen Jul 14, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This phase 2 study tests whether a radioactive tracer called [68Ga]BED003 can improve PET/CT scans for detecting cancer in the peritoneum (the lining of the abdomen). The trial includes adults with colorectal, ovarian, gastric, pancreatic, or a type of breast cancer. Researchers will compare the scan results with standard methods to see how accurately the tracer identifies cancer spread.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- [68Ga]BED003, a radioactive tracer for PET/CT imaging
- What this could lead to
- If successful, this imaging agent could help doctors spot cancer spread in the abdomen more accurately, guiding better treatment decisions.
- What could go wrong
- This is an early-phase study with only 65 participants, so results may not apply to all patients. The tracer may not perform better than current imaging methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII
RECRUITINGBergamo, Lombardy, 24127, Italy
Contact
-
Fondazione IRCCS San Gerardo dei Tintori
NOT_YET_RECRUITINGMonza, Lombardy, 20900, Italy
Contact
-
Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore
NOT_YET_RECRUITINGRoma, Roma, 00136, Italy
Contact
-
IRCCS Ospedale San Raffaele
RECRUITINGMilan, Segrate, 20132, Italy
Contact
-
Stichting Radboud Universitair Medisch Centrum
RECRUITINGNijmegen, 6525, Netherlands
Contact
-
University Medical Center Groningen
RECRUITINGGroningen, 9713, Netherlands
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who will survive a bowel surgery leak?
- Can a Two-Drug attack shrink Hard-to-Treat colorectal tumors?
- Can a custom mRNA vaccine keep ovarian cancer from coming back?
- Can a new drug ST316 shrink Hard-to-Treat tumors?
- A mobile app aims to turn health awareness into action — a trial puts it to the test
- Can a walking routine alter cancer biomarkers? new trial investigates